Inhaler Overuse Linked to Cardiovascular Death Risk
Analysis based on 6 articles · First reported Aug 26, 2026 · Last updated Sep 10, 2026
The findings could modestly weigh on makers of short-acting bronchodilator inhalers if they prompt tighter prescribing and greater use of maintenance therapies, while supporting demand for respiratory and cardiovascular monitoring. Overall market impact is limited because the study is observational, does not establish causation, and does not change any regulatory or commercial status.
A large observational study published in ERJ Open Research found that overuse of short-acting reliever inhalers among asthma and COPD patients is associated with higher risks of cardiovascular disease and death, including heart failure, heart attack and ischemic stroke. The research, led by Lies Lahousse of Ghent University in Belgium and Erasmus MC in the Netherlands, analyzed real-world primary and secondary care data from more than 280,000 asthma and COPD patients in Belgium who used SABA, SAMA, both, or no short-acting bronchodilators. Compared with no use, SABA use was associated with a 12% higher risk of death in asthma patients and 14% in COPD patients, while SAMA use was associated with a 73% higher risk in asthma and 36% in COPD. Using three or more reliever inhalers per year was linked to higher mortality than using two or fewer, and patients without prior cardiovascular disease appeared particularly vulnerable. The authors caution that the observational design cannot prove causation, since frequent reliever use may itself be a marker of poorly controlled lung disease. Pavol Pobeha of the European Respiratory Society, based at Pavol Jozef Šafárik University in Slovakia, who was not involved in the research, said relievers remain essential for symptom management but called for better monitoring systems to flag overuse. The team plans further work on whether stricter adherence to maintenance treatment reduces reliever overuse and whether cardiovascular risk assessment can lower risks for these patients.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard